Search Results 731-740 of 17271 for lupus

1. Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) with Avelumab in Muscle Invasive Bladder Cancer - Mayo Clinic

   Known diagnosis of any condition (i.e. post-hematopoietic or organ transplant, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, ...

2. A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases - Mayo Clinic

   Diagnosed or suspected systemic lupus erythematosus (SLE) and/or rheumatoid arthritis (RA); Hepatocellular carcinoma (HCC) at entry into the study; History of ...

3. Biobanking Study in Immunodeficiency Patients - Mayo Clinic

   Primary immunodeficiencies (PID) are diseases that affect any part of multiple components of the immune system, resulting in abnormal and/or impaired immune ...

4. A Study to Assess the Effectiveness and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

   ... lupus, inflammatory bowel disease, rheumatoid arthritis, etc.), other severe endocrinological, gastrointestinal, metabolic, pulmonary, or lymphatic diseases ...

5. Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion - Mayo Clinic

   History of antiphospholipid syndrome, in particular triple positive (lupus anticoagulant, anticardiolipin antibodies, and anti-beta 2-glycoprotein I antibodies).

6. Blood in urine (hematuria) - Doctors and departments - Mayo Clinic

   ... Lupus nephritis, Renal tubular acidosis, Renovascular disease, Minimal change disease, Membranoproliferative glomerulonephritis, Medullary sponge kidney ...

7. Rituximab-arrx (intravenous route) - Mayo Clinic

   Wash your hands often. Tell your doctor if you have lupus or if you have any kind of infection before you start receiving this medicine. Also tell your doctor ...

8. Ipilimumab (intravenous route) - Mayo Clinic

   Autoimmune disease (eg, Crohn disease, lupus, sarcoidosis, ulcerative colitis) or; Colitis (inflammation of the bowel) or; Diabetes or; Eye or vision problems ...

9. Lioudmila V. Karnatovskaia, M.D. - Mayo Clinic Faculty Profiles

   Mayo Clinic researcher Lioudmila V. Karnatovskaia, M.D., strives to improve outcomes for people surviving critical illnesses.

10. Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) - Mayo Clinic

    ... lupus erythematosus, polymyositis/dermatomyositis, and Raynaud's phenomenon was conducted in order to develop classification criteria for systemic sclerosis.